Six-month follow-up of the patients with the low-grade femoral cartilage 
lesions using T2 mapping at 3 and 7 Tesla

Juras, V; Schreiner, M; Heule, R; Szomolanyi, P; Zbyn, S; Mlynarik, V; Marlovits, S; Laurent, D; Scotti, C; Goldhahn, J; Kubiak, E; Haber, H; Frollo, I; Bieri, O; Trattnig, S

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben

Poster

Six-month follow-up of the patients with the low-grade femoral cartilage lesions using T2 mapping at 3 and 7 Tesla

MPG-Autoren

Es sind keine MPG-Autoren in der Publikation vorhanden

Externe Ressourcen

https://archive.ismrm.org/2017/1532.html
(Zusammenfassung)

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

Es sind keine frei zugänglichen Volltexte in PuRe verfügbar

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Juras, V., Schreiner, M., Heule, R., Szomolanyi, P., Zbyn, S., Mlynarik, V., et al. (2017). Six-month follow-up of the patients with the low-grade femoral cartilage lesions using T2 mapping at 3 and 7 Tesla. Poster presented at 25th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2017), Honolulu, HI, USA.

Zitierlink: https://hdl.handle.net/21.11116/0000-000B-0429-3

Zusammenfassung

Transverse relaxation time (T2) maps were assessed as a potential marker for the long-term follow-up of the patients with cartilage lesions ICRS Grade I-II in four time points (baseline, 8 days, 3 and 6 months). T2 mapping was based on a 3D triple echo steady state imaging sequence delivering high quality high-resolved T2 maps at ultra-high field MRI. The results showed opposite trends of T2 values at 3T (a decrease) and 7T (an increase) over time. The statistically significant difference was found in case of deep zone of the cartilage lesion at 3T. T2 mapping could be used in the future as a good alternative to cartilage biopsies in clinical trials on new therapies aimed at cartilage regeneration.